Aristotelis G. Anastasiadis completed his medical studies as well as his doctoral degree at the Christian-Albrecht-Universität of Kiel, Germany.

He then continued his training in the Department of Urology, Heinrich-Heine-Universität Düsseldorf, Germany. His residency in Urology also included one year of Obstetrics and Gynecology, and one year of General surgery. He completed his residency training in 1999.

In 2000, he was awarded an American Foundation for Urologic Disease (A.F.U.D.)/American Urological Associaton (A.U.A.) MD Post-Residency Research Scholarship entitled “Therapeutic Resistance of Prostate Cancer Mediated by Hypoxia Response Genes”, grant # MD0101. He was a Research Scholar in the Department of Urology, Columbia University College of Physicians and Surgeons in New York, NY, USA until 2003.

After he returned to Germany, Dr. Anastasiadis continued his academical and clinical career at the Department of Urology, University of Tuebingen. In 2004, he completed his post-doctorate thesis: “In Vitro Examinations on Molecular Effects of Hypoxia on Prostate and Prostate Carcinoma Cells”, and was appointed assistant Professor of Urology in 2008.

Aristotelis G. Anastasiadis completed his medical studies as well as his doctoral degree at the Christian-Albrecht-Universität of Kiel, Germany.

He then continued his training in the Department of Urology, Heinrich-Heine-Universität Düsseldorf, Germany. His residency in Urology also included one year of Obstetrics and Gynecology, and one year of General surgery. He completed his residency training in 1999.

In 2000, he was awarded an American Foundation for Urologic Disease (A.F.U.D.)/American Urological Associaton (A.U.A.) MD Post-Residency Research Scholarship entitled “Therapeutic Resistance of Prostate Cancer Mediated by Hypoxia Response Genes”, grant # MD0101. He was a Research Scholar in the Department of Urology, Columbia University College of Physicians and Surgeons in New York, NY, USA until 2003.

After he returned to Germany, Dr. Anastasiadis continued his academical and clinical career at the Department of Urology, University of Tuebingen. In 2004, he completed his post-doctorate thesis: “In Vitro Examinations on Molecular Effects of Hypoxia on Prostate and Prostate Carcinoma Cells”, and was appointed assistant Professor of Urology in 2008.